These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24103590)

  • 1. RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI.
    Zhang J; Ma W; Tian S; Fan Z; Ma X; Yang X; Zhao Q; Tan K; Chen H; Chen D; Huang BR
    Cell Signal; 2014 Jan; 26(1):162-72. PubMed ID: 24103590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ran-binding protein RanBPM can depress the NF-κB pathway by interacting with TRAF6.
    Wang L; Fu C; Cui Y; Xie Y; Yuan Y; Wang X; Chen H; Huang BR
    Mol Cell Biochem; 2012 Jan; 359(1-2):83-94. PubMed ID: 21805090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
    Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
    Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ran binding protein RanBPM interacts with TrkA receptor.
    Yuan Y; Fu C; Chen H; Wang X; Deng W; Huang BR
    Neurosci Lett; 2006 Oct; 407(1):26-31. PubMed ID: 16959415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ran binding protein 9 (RanBPM) binds IFN-λR1 in the IFN-λ signaling pathway.
    Zhang J; Cong X; Zhaoqiao J; Yang X; Li M; Chen H; Mi R; Jin G; Liu F; Huang BR
    Sci China Life Sci; 2017 Sep; 60(9):1030-1039. PubMed ID: 28547582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RanBPM contributes to TrkB signaling and regulates brain-derived neurotrophic factor-induced neuronal morphogenesis and survival.
    Yin YX; Sun ZP; Huang SH; Zhao L; Geng Z; Chen ZY
    J Neurochem; 2010 Jul; 114(1):110-21. PubMed ID: 20403074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor through polyubiquitination and activation of presenilin 1.
    Gudey SK; Sundar R; Mu Y; Wallenius A; Zang G; Bergh A; Heldin CH; Landström M
    Sci Signal; 2014 Jan; 7(307):ra2. PubMed ID: 24399296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells.
    Kim SI; Kwak JH; Na HJ; Kim JK; Ding Y; Choi ME
    J Biol Chem; 2009 Aug; 284(33):22285-22296. PubMed ID: 19556242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
    Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
    J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
    Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
    Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
    Morlon A; Munnich A; Smahi A
    Hum Mol Genet; 2005 Dec; 14(23):3751-7. PubMed ID: 16251197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-molecule force spectroscopy study of interaction between transforming growth factor beta1 and its receptor in living cells.
    Yu J; Wang Q; Shi X; Ma X; Yang H; Chen YG; Fang X
    J Phys Chem B; 2007 Dec; 111(48):13619-25. PubMed ID: 17997544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
    Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
    Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer.
    Mu Y; Sundar R; Thakur N; Ekman M; Gudey SK; Yakymovych M; Hermansson A; Dimitriou H; Bengoechea-Alonso MT; Ericsson J; Heldin CH; Landström M
    Nat Commun; 2011; 2():330. PubMed ID: 21629263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH; Derynck R
    EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RanBPM, a novel interaction partner of the brain-specific protein p42IP4/centaurin alpha-1.
    Haase A; Nordmann C; Sedehizade F; Borrmann C; Reiser G
    J Neurochem; 2008 Jun; 105(6):2237-48. PubMed ID: 18298663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
    J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.